Knowledge Base Category -

 Medicare Coverage
MMP Logo no Words or Tag
February 2022 Medicare Transmittals and MLN Articles Updates
Published on Feb 23, 2022
20220223
 | Coding 
 | Billing 

Medicare MLN Articles & Transmittals – Recurring Updates

Expedited Review Process for Hospital Inpatients in Original Medicare
  • Article Release Date: January 21, 2022
  • What You Need to Know: CMS has reformatted the current instructions for delivery of the Important Message from Medicare (IMM) and the beneficiary’s rights to an expedited review. While this MLN article notes in bold to “make sure your staff knows this is a reformatting of the current instructions and there are no policy or instructional changes,” following are three noteworthy clarifications:
    • The effective date for the related Change Request is April 21, 2022.
    • A new exception of who you would not provide an IMM to is the beneficiary that ends care on their own initiative by electing the hospice benefit.
    • A new note indicates “the IM should only be given when an inpatient admission is pending or has occurred. It should not be given ‘just in case,’ such as a hospital delivering to all Medicare patients being treated in a hospital emergency room.”
    • CMS has included a statement that “an IM must be delivered even if the beneficiary agrees with the discharge.”
  • MLN MM12546: (link)
Internet-Only Manual Updates for Critical Care Evaluation and Management Services
  • Article Release Date: January 22, 2022
  • What You Need to Know: You will learn about critical care updates for a patient in a global surgical period and the use of modifier FT.
  • MLN MM12550: (link)
Quarterly Update for Clinical Laboratory Fee Schedule (CLFS) and Laboratory Services Subject to Reasonable Charge Payment
  • Article Release Date: January 27, 2022
  • What You Need to Know: This article provides instructions for the April 2022 update to the CLFS and new codes effective April 1, 2022.
  • MLN MM12612: (link)
International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to National Coverage Determinations (NCDs)—July 2022
  • Article Release Date: February 10, 2022
  • What You Need to Know: This article provides information about newly available codes, separate NCD coding revisions, and coding feedback.
  • MLN MM12606: (link)
Gap Billing Between Hospice Transfers
  • Article Release Date: February 10, 2022
  • What You Need to Know: A new CWF edit will no longer allow gaps of care to occur during a transfer.
  • MLN 12619: (link)
Omnibus Change Request to Remove Two NCDs, Updates Medical Nutritional Therapy Policy and Updates to Pulmonary Rehabilitation, (PR), Cardiac Rehabilitation (CR), and Intensive Cardiac Rehabilitation (ICR) Conditions of Coverage
  • Change Request 12613/Transmittal 11272 Release Date: February 18, 2022
  • What You Need to Know: Updates became effective January 1, 2022, by statute with an implementation date of July 5, 2022. Specific to PR, the CY 2022 MPFS final rule removed the requirements for direct physician-patient contact and expanded coverage of PR for beneficiaries with confirmed or suspected COVID-19 and experience persistent symptoms that include respiratory dysfunction for at least 4 weeks. The two NCDs being removed are:
  • NCD 180.2 Enteral/Parenteral Nutritional Therapy, and
  • NCD 220.6 Positron Emission Tomography (PET) Scans.
  • Transmittal 11272: (link)

Revised Medicare MLN Articles & Transmittals

April 2022 Update to the MS-DRG Group and Medicare Code Editor Version 39.1 for ICD-10 Diagnosis Codes for 2019 COVID-19 Vaccination Status and ICD-10-PCS codes for Introduction or Infusion of Therapeutics and Vaccines for COVID-19 Treatment
  • Article Release Date: Initial article January 19, 2022 – Revised February 8, 2022
  • What You Need to Know: This article was revised to add two new procedure codes describing the introduction or infusion of therapeutics including vaccines for COVID-19 treatment, effective April 1, 2022.
  • MLN MM12578: (link)

Beth Cobb

Happy American Heart Month
Published on Feb 16, 2022
20220216
 | Coding 
 | Billing 

Did You Know?

February is American Heart Month. Per NCD 210.11 (link), cardiovascular disease (CVD):

  • Is the leading cause of mortality in the United States,
  • Is comprised of hypertension, coronary artery disease (i.e., myocardial infarction and angina pectoris), heart failure and stroke, and
  • Is the leading cause of hospitalizations.

Risk Factors for CVD includes:

  • Being overweight,
  • Obesity,
  • Physical inactivity,
  • Diabetes,
  • Cigarette smoking,
  • High Blood Pressure (HTN),
  • High blood cholesterol,
  • Family history of myocardial infarction, and
  • Older age

Why this Matters?

Annually, the CERT publishes a supplemental improper payment data report. Table D4, in the supplemental report (link), highlights the top 20 service types with the highest improper payments for Part A IPPS Hospitals. This table also details the percentage of error by each of the CERT’s major error categories:

  • No documentation,
  • Insufficient documentation,
  • Medical necessity.
  • Incorrect coding, and
  • Other.

In the 2021 supplemental data, nine of the top twenty service types with highest improper payments were DRGs in the major diagnostic category (MDC) 5 Diseases and Disorders of the Circulatory System. Insufficient documentation and medical necessity were the two most common type of errors cited for this group of service types.

The projected improper payment for the circulatory system service types is $714,632,739 representing 36% of the total projected improper payments for the top twenty service types.

What Can You Do?

Be proactive for your patients by becoming familiar with the cardiovascular disease screening tests and intensive behavioral therapy for cardiovascular disease covered by Medicare and additional resources published in the February 10, 2022 edition of MLN Connects (link):

  • Preventive Services webpage (link)
  • Achieving Health Equity web-based training (link)
  • CMS Office of Minority Health, Health Observances webpage (link)
  • Million Hearts® (link): HHS initiative to prevent a million heart attacks and strokes
  • Cardiovascular disease screenings coverage (link) & behavioral therapy (link): information for your patients

Become familiar with coverage determinations related to the top services. For example:

  • For DRGs 226 and 227 (Cardiac Defibrillator Implant without cardiac catheterization with MCC and without MCC respectively), there is a National Coverage Determination (NCD 20.4) and Medicare Administrative Contractor (MAC) specific Local Coding and Billing Articles.
  • Transcatheter Aortic Valve Replacement (TAVR) and TEER (Transcatheter Edge-to-Edge Repair) procedures fall within DRGs 266 and 267. Both procedures have a related NCD (TAVR NCD 20.32 and TEER NCD 20.33).
  • Percutaneous Left Atrial Appendage Closure (LAAC) procedures fall within DRGs 273 and 274 and has a related NCD (20.34).
  • For DRG 313 (Chest Pain), Palmetto GBA the Jurisdiction J and M MAC, has a Local Coverage Determination (LCD L34551) titled, One Day Stays for Chest Pain.

Finally, respond to requests for documentation in a timely manner, sending adequate documentation to support the medical necessity of the services provided.

Beth Cobb

New Inpatient Unspecified Code Edit 20
Published on Feb 09, 2022
20220209
 | Coding 
 | Billing 

Did You Know?

In October 2021, CMS published Change Request (CR) 12471 (link). There were two stated purposes for this CR noted in the Summary of Changes:

  • • Implement system changes needed to update the Shared System Maintainer (SSM) interface with the Java MCE to accept new MCE Edit 20-Unspecific Code Edit, and
  • • Provide a mechanism to systematically bypass the new edit when a specific billing note is present in the claim remarks field to indicate the primary reason why laterality could not be determined

The effective date for this CR is April 1, 2022.

Why this Matters?

In ICD-10-CM there are unspecified codes for when documentation in the record does not provide detail needed to report a more specific code. “However, in the inpatient setting, there should generally be very limited and rare circumstances for which the laterality (right, left, bilateral) of a condition is unable to be documented and reported.”

Effective for claims with dates of service on or after April 1, 2022, new Code Edit 20- will be triggered when an unspecified diagnosis code currently designated as either a Complication or Comorbidity (CC) or Major Complication or Comorbidity (MCC), that includes other codes in that code subcategory that further specify the anatomic site, is entered.

You will find the complete list of 3,432 ICD-10-CM unspecified codes subject to this edit in table 6P.3a associated with the FY 2022 IPPS/LTCH Final Rule (link).

This edit is meant to signal providers that there is a more specific laterality code available to report. It will be the providers responsibility to determine if documentation in the medical record support’s a more specific code. “If, upon review, additional information to identify the laterality from the available medical record documentation by any other clinical provider is unable to be obtained or there is documentation in the record that the physician is clinically unable to determine the laterality because of the nature of the disease/condition, then the provider must enter that information in the remarks section.

Mechanism to Bypass new MCE Edit 20-

The provider may enter a remark:

  • • Either “UNABLE TO DET LAT 1” to indicate that they are unable to obtain additional information to specify laterality, or
  • • “UNABLE TO DET LAT 2” to indicate the physician is clinically unable to determine laterality

However, “if there is no language entered into the remarks section as to the availability of additional information to specific laterality and the provider submits the claim for processing, the claim would be returned to the provider.”

“0 or 1 day” Length of Stay Claims

After reading this CR, my first thought was, how often are one of these codes being included on a claim. To find the answer, I turned to our sister company, RealTime Medicare Data (RTMD). Following are the numbers for Medicare Fee-for-Service paid claims data with dates of service from October 1, 2020, through August 31, 2021, available in RTMD’s footprint:

  • • 57,951 claims included one of the unspecified codes in Table 6P.3a of the FY 2022 IPPS/LTCH Final Rule,
  • • The paid claims total for this set of claims was $1,010,178,584.54, and
  • • The top five states by claims volume included:
    • o California: 5,926 claims - $135,738,052.81
    • o Texas: 5,872 claims - $104,453,156.02
    • o New York: 3,290 claims - $70,001,125.23
    • o Pennsylvania: 3,192 claims - $48,281,839.67
    • o Illinois: 2,750 claims - $41,821,442.35

What Can You Do?

This is not a large volume of claims in the world of Medicare Fee-for-Service Inpatient paid claims. However, just over $1 billion in paid claims is a significant amount of money. With a little over a month to prepare, you should make sure that CR 12471 and related MLN Matters article MM12471(link) are shared with key stakeholders at your facility (i.e., Billing, Coding, Clinical Documentation Integrity Specialists). You should also work with your IT department to anticipate the potential volume of claims that will be impacted by the new Code Edit 20-.

Beth Cobb

January 2022 COVID-19 Updates
Published on Jan 26, 2022
20220126
 | Billing 
 | Coding 
January 5, 2022: CDC Expands Booster Shot Eligibility for 12-17 Year Old’s

The CDC announced in a newsroom release (link), they are endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. They are also recommending that those 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.

January 7, 2022: New HCPCS Code for Remdesivir Antiviral Medication

CMS issued a Special Edition MLN Connects (link) to let providers know they had created a HCPCS code J0248 for VEKLURY™ (remdesivir) antiviral medication when administered in the outpatient setting. This code is available for use by all payers and is effective for dates of service on or after December 23, 2021. They note that the MACs will determine Medicare coverage for HCPCS code J0248 administered in the outpatient setting and the MACs will be sharing coverage and claims processing information for this code.

December 31, 2021: CDC Health Advisory – Using Therapeutics to Prevent and Treat COVID-19
January 12, 2022: 2 New Procedure Codes Effective April 1, 2022

CMS published an ERRATA (link) to the ICD-10 MS-DRGs Version 39.1 effective April 1, 2022 to inform providers of “2 new procedure codes, in addition to the 7 new procedure codes previously announced, bringing the total to 9 new procedure codes, to describe the introduction of infusion or therapeutics, including vaccines for COVOID-19 treatment, into the” ICD-10-PCS. The 2 new codes are:

  • XW023X7: Introduction of tixagevimab and cilgavimab monoclonal antibody into muscle, percutaneous approach, new technology group 7, and
  • XW023Y7: Introduction of other new technology monoclonal antibody into muscle, percutaneous approach, new technology group 7.
January 13, 2022: COVID-19 Updates in CMS MLN Connects

The Thursday January 13th edition of MLN Connects (link) included information and resources about the following topics:

  • Updated Materials for Visiting Nursing Homes During Omicron Surge,
  • Vaccine Access in Long-Term Care Settings,
  • New HCPCS Code for Remdesivir Antiviral Medication – Updated NIH Treatment Guidelines Panel Link, and
  • Pfizer Booster Doses for Ages 12+ & Immunocompromised Ages 5-11.
January 14, 2022: Public Health Emergency Declaration due to COVID-19 Renewed

As expected, the COVID-19 Public Health Emergency was extended again on Friday, January 14th (link). This means waivers will remain in effect for 90 days (April 14, 2022).

April 2022 Update to the Medicare Severity-Diagnosis Related Group (MS-DRG) Grouper and Medicare Code Editor (MCE) Version 39.1 for ICD-10 Diagnosis Codes for 2019 COVID-19 Vaccination Status and ICD-10-PCS Codes for Introduction or Infusion of Therapeutics and Vaccines for COVID-19 Treatment
January 24, 2022: Free At-Home COVID-19 Tests

The CDC’s January 24th COVID-19 updates included a notice (link) that “every home in the United States is eligible to order 4 free at-home COVID-19 rapid antigen tests. Orders will usually ship in 7-12 days. These tests give results within 30 minutes (no lab drop-off required).” You can also go to https://www.covidtests.gov/ to order your tests.

Beth Cobb

January 2022 Medicare Transmittals and Coverage Updates
Published on Jan 26, 2022
20220126
 | Billing 
 | Coding 

Medicare MLN Articles & Transmittals – Recurring Updates

Clinical Laboratory Fee Schedule – Medicare Travel Allowance for Collection of Specimens
  • • Article Release Date: January 18, 2022
  • • What You Need to Know: This article provides information about CY 2022 changes to travel allowances when you bill on a per mileage basis and on a flat rate basis.
  • • MLN MM12593: https://www.cms.gov/files/document/mm12593-clinical-laboratory-fee-schedule-medicare-travel-allowance-fees-collection-specimens.pdf
Internet-Only Manual Updates (IOM) for Critical Care, Split/Shared Evaluation and Management Visits, Teaching Physicians, and Physician Assistants
  • • Article Release Date: January 18, 2022
  • • What You Need to Know: You will learn about Medicare manual revisions for critical care services, split/shared E&M visits, teaching physician services and physician assistant billing and payment.
  • • MLN MM12543: https://www.cms.gov/files/document/mm12543-internet-only-manual-updates-iom-critical-care-split-shared-evaluation-and-management-visits.pdf
New Waived Tests
  • • Article Release Date: January 18, 20221
  • • What You Need to Know: You will learn about the latest tests approved by the FDA as waived tests under CLIA, laboratory claim edits, and facility certification requirements.
  • • MLN MM12581: https://www.cms.gov/files/document/mm12581-new-waived-tests.pdf
CY 2022 Telehealth Update Medicare Physician Fee Schedule
  • • Article Release Date: January 19, 2022
  • • What You Need to Know: There are two additional modifiers for CY 2022 for telehealth services and this article includes a link to the updated telehealth services list.
  • • MLN MM12549: https://www.cms.gov/files/document/mm12549-cy2022-telehealth-update-medicare-physician-fee-schedule.pdf
Healthcare Common Procedure Coding System (HCPCS) Codes Subject to and Excluded from Clinical Laboratory Improvement (CLIA) Edits
  • • Article Release Date: January 20, 2022
  • • What You Need to Know: You will learn about discontinued and new HCPCS codes and which codes are subject to and excluded from CLIA edits.
  • • MLN MM12573: https://www.cms.gov/files/document/mm12573-healthcare-common-procedure-coding-system-hcpcs-codes-subject-and-excluded-clinical.pdf
Expedited Review Process for Hospital Inpatients in Original Medicare
  • • Article Release Date: January 21, 2022
  • • What You Need to Know: CMS has reformatted the manual section of chapter 30 of the Medicare Claims Processing Manual to improve “readability and understanding.” CMS makes a point to note in bold font that no policy or instructional changes have been made.
  • • MLN MM12546: https://www.cms.gov/files/document/mm12546-expedited-review-process-hospital-inpatients-original-medicare.pdf

Revised Medicare MLN Articles & Transmittals

International Classification of Diseases, 10th revision (ICD-10) and Other Coding Revisions to National Coverage Determinations (NCDs) – April 2022 (CR 1 of 2)
  • • Article Release Date: Initial article November 1, 2021 – Revised January 13, 2022
  • • What You Need to Know: The CR release date, transmittal number, and the web address of the CR has been updated. The revisions did not affect the substance of the article.
  • • MLN MM12480: https://www.cms.gov/files/document/mm12480-international-classification-diseases-10th-revision-icd-10-and-other-coding-revisions.pdf
Calendar year (CY) 2022 Annual Update for Clinical Laboratory Fee Schedule and Laboratory Services Subject to Reasonable Charge Payment
  • • Article Release Date: Initial article December 13, 2021 – Revised January 13, 2022
  • • What You Need to Know: This article was revised to show the delay in the CLFS data reporting period for clinical diagnostic lab tests and note the delay in the application of the 15% phase-in reduction.
  • • MLN MM12558: https://www.cms.gov/files/document/mm12558-calendar-year-cy-2022-annual-update-clinical-laboratory-fee-schedule-and-laboratory-services.pdf

Medicare Coverage Updates

January 11, 2022: Proposed Decision Memo for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

CMS published a Proposed Decision Memorandum (https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&ncaid=305&fromTracking=Y&)88 in which they are proposing to cover FDA approved monoclonal antibodies that target amyloid for the treatment of Alzheimer’s disease through Coverage with Evidence Development (CED). The public comment period is from January 11, 2022 through February 20, 2022. You can read more about this proposed policy in a related CMS Press Release (https://www.cms.gov/newsroom/press-releases/cms-proposes-medicare-coverage-policy-monoclonal-antibodies-directed-against-amyloid-treatment)88.

Medicare Educational Updates

CMS MLN Fact Sheet: Original Medicare vs. Medicare Advantage

This MLN Fact Sheet (https://www.cms.gov/files/document/mln8659122-original-medicare-vs-medicare-advantage.pdf)88 describes what providers need to know about how different coverage affects seeing patients, processing claims and filing appeals.

Beth Cobb

New PEPPER Target: Severe Malnutrition
Published on Jan 12, 2022
20220112
 | Billing 
 | Coding 
 | OIG 
Did You Know?

Malnutrition and more specifically, severe malnutrition has been in the audit spotlight for several years. Historically, the OIG completed a series of reviews of hospitals with claims that included the ICD-9 diagnosis code for Kwashiorkor (260). In a December 2017 Report Brief (link), the OIG “reviewed the medical records for 2,145 inpatient claims at 25 providers and found that all but 1 claim incorrectly included the diagnosis code for Kwashiorkor, resulting in overpayments in excess of $6 million.”

They identified a discrepancy in the ICD-CM coding classification between the tabular list and the alpha index on the use of diagnosis code 260 and stated “CMS did not have adequate policies and procedures in place to address this discrepancy, resulting in a total potential loss of approximately $102 million during CYs 2006 through 2015. Even though CMS was aware of the discrepancy, it did not take any separate action to address it.”

In July 2020, the OIG published a Report Brief (link), looking at ICD-10-CM severe malnutrition diagnosis codes E41 (nutritional marasmus) and E43 (unspecified severe protein calorie malnutrition). The OIG found that 164 of 200 claims had billing errors resulted in net overpayments of $914,128 and stated, “the errors occurred because hospital used severe malnutrition diagnosis codes when they should have used codes for other forms of malnutrition or no malnutrition diagnosis code at all.” Based on the sample of claims reviewed, the OIG estimated hospitals received overpayments of $1 billion for FYs 2016 and 2017.

Most recently, in November 2021, the OIG added a review of Medicaid inpatient hospital claims with severe malnutrition to their Work Plan (link). The Work Plan issue description, indicates “adding an MCC to a claim can result in an increased payment by causing the claim to be coded in a higher diagnosis-related group.”

In addition to the OIG, the Q3 Fiscal Year (FY) 2021 Program for Evaluation Payment Patterns Electronic Report (PEPPER) became available and includes the new risk area, severe malnutrition. More specifically, this new PEPPER Target Area focuses on DRGs assigned based on an MCC with one of the following malnutrition ICD-10-CM diagnosis codes as the only MCC:

  • E40: Kwashiorkor
  • E41: Nutritional Marasmus
  • E42: Marasmic kwashiorkor
  • E43: Unspecific severe protein-calorie malnutrition

The Thirty-Fourth Edition of the Short-Term Acute Care PEPPER User’s Guide (link) provides the following guidance for hospitals that are high outliers for this new risk area:

“This could indicate that there are coding errors related to unsubstantiated coding of one of the severe malnutrition codes (i.e., E40, E41, E42, or E43) as the only MCC. A sample of medical records with a severe malnutrition code as the only MCC should be reviewed to determine whether coding errors exist. A diagnosis of severe malnutrition must be determined by the physician. A coder should not code based on laboratory findings or nutritional consultation without seeking physician determination of the clinical significance of the abnormal findings.”

Severe Malnutrition by the Numbers

As severe malnutrition has been and continues to be a focus of audit, I turned to our sister company RealTime Medicare Data (RTMD) to try and understand how often one of the above severe malnutrition ICD-10-CM diagnosis codes continues to be the only MCC coded on a record. RTMD data is Medicare Fee-for-Service specific and includes inpatient discharges, outpatient services, and CMS 1500 Professional services. It is full-census, non-modeled, and typically available 90 days post-payment.

The data provided by RTMD for this article includes calendar years (CYs) 2019 and 2020 inpatient claims for the entire RTMD footprint. Here is what I found.

CY 2019 and 2020 combined:

  • 188,383 total claims paid where a severe malnutrition code was the only MCC on the claim.
  • Actual Total Payment: Just over $2.9 billion
  • >
  • The five states with the highest number of claims for both CYs included Florida, California, New York, Texas, and Illinois.

CY 2019:

  • 102,874 total paid claims
  • Actual Total Payment: $1,543,413,978
  • Volume of claims by ICD-10-CM diagnosis code:
    • E40 Kwashiorkor – 13 claims
    • E41 Nutritional Marasmus – 235 claims
    • E42 Marasmic Kwashiorkor – 4 claims
    • E43 Unspecified severe protein-calorie malnutrition – 102,622 claims
  • Claims where one of the four severe malnutrition codes was the only secondary diagnosis on the claim:
    • 8,506 claims
    • Actual Total Payment: $114,480,291

CY 2020

  • 85,509 claims
  • Actual Total Payment: $1,367,094,959
  • Volume of claims by ICD-10-CM diagnosis code:
    • E40 Kwashiorkor – 12 claims
    • E41 Nutritional Marasmus – 117 claims
    • E42 Marasmic Kwashiorkor – 10 claims
    • E43 Unspecified severe protein-calorie malnutrition – 85,370 claims
  • Claims where one of the four severe malnutrition codes was the only secondary diagnosis on the claim:
    • 8,101 claims
    • Actual Total Payment: $114,246,389
Moving Forward
  • Make sure key stakeholders (i.e., Physicians, Coding Professionals, Clinical Documentation Integrity Specialists, and Registered Dieticians) at your facility are familiar with the 2012 ASPEN/AND criteria and the 2018 Global Leadership Initiative on Malnutrition (GLIM) criteria,
  • Partner with your medical staff to standardize the criteria your hospital uses to define the types of malnutrition (i.e., Kwashiorkor, Nutritional Marasmus),
  • Monitor your quarterly PEPPER to see if your hospital is an outlier in this risk area,
  • Respond in a timely manner to medical record requests made by auditing entities.

Beth Cobb

Is a New Long-Acting Monoclonal Antibodies for Pre-Exposure Prevention of COVID-19 an Option for You?
Published on Jan 12, 2022
20220112
 | Billing 
 | Coding 

In December 2021, the FDA announced (link) an Emergency Use Authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 40 kg [about ">link) pounds]).

According to the announcement, Evusheld is for people not currently infected with or who have not had recent exposure to an individual who has COVID-19. Additionally, the EUA requires that the individual either have:

  • “moderate to severely compromised immune systems due to a medical condition or due to taking immunosuppressive medications or treatments and may not mount an adequate immune response to COVID-19 vaccination (examples of such medical conditions or treatments can be found in the fact sheet for health care providers) or;
  • a history of severe adverse reactions to a COVID-19 vaccine and/or component(s) of those vaccines, therefore vaccination with an available COVID-19 vaccine, according to the approved or authorized schedule, is not recommended.”

The FDA reinforces the fact that this medication is not a substitute for a COVID-19 vaccine and “urges the public to get vaccinated if eligible.” They also advise patients to talk with their health care provider to determine if this is an appropriate prevention option.

CMS has updated their COVID-19 Vaccines and Monoclonal Antibodies webpage (link) to include the code and the national payment allowance for Evusheld.

Also, CMS reminded providers in the December 16 edition of MLN Connects (link) that “if you vaccinate or administer monoclonal antibody treatment to patients enrolled in Medicare Advantage (MA) plans on or after January 1, 2022, submit claims to the MA Plan. Original Medicare won’t pay these claims.”

Beth Cobb

December & Early January 2022 Medicare Transmittals and Coverage Updates
Published on Jan 05, 2022
20220105
 | Billing 
 | Coding 

Medicare MLN Articles & Transmittals – Recurring Updates

Addition of the QW Modifier to Healthcare Common Procedure Coding System (HCPCS) Code 86328
  • Article Release Date: December 10, 2021
  • What You Need to Know: You will find information about the addition of the QW modifier to HCPCS 86328, the Emergency Use Authorization (EUA) that the FDA can issue during Public Health Emergencies (PHEs), and the first EUA issued to detect COVID-19 antibodies for use in patient care.
  • MLN MM12557: (link)
January 2022 Update of the Hospital Outpatient Prospective Payment System (OPPS)
  • Article Release Date: December 13, 2021
  • What You Need to Know: This article provides information about new COVID-19 CPT vaccine and administration codes, OPPS updates for January 2022 and new drugs, biologicals, and radiopharmaceuticals.
  • MLN MM12552: (link)
Calendar Year (CY) 2022 Annual Update for Clinical Laboratory Fee Schedule and Laboratory Services Subject to Reasonable Charge Payment
  • Article Release Date: December 13, 2021
  • What You Need to Know: You will find instructions for the CY 2022 Clinical Laboratory Fee Schedule (CLFS), mapping for new codes for clinical laboratory tests, and updates for laboratory costs subject to the reasonable charge payment.
  • MLN MM12558: (link)
January 2022 Update of the Ambulatory Surgical Center (ASC) Payment System
  • Article Release Date: December 16, 2021
  • What You Need to Know: You will find information about updates to the ASC payment system in January 2022, payment offsets for HCPCS codes C1832 and C1833, and changes to the ASC Covered Procedure List Policy for CY 2022.
  • MLN MM12553: (link)
Changes to the Laboratory National Coverage Determination (NCD) Edit Software for April 2022
  • Article Release Date: December 22, 2021
  • What You Need to Know: This article alerts providers that April 2022 changes to the NCD Edit Software is available.
  • MLN MM12575: (link)

Revised Medicare MLN Articles & Transmittals

Claims Processing Instructions for the New Pneumococcal 15-valent Conjugate Vaccine Code 90671 and Pneumococcal 20-valent Conjugate Vaccine Code 90677
  • Article Release Date: Initial article November 1, 2021– Revised December 15, 2021
  • What You Need to Know: This article has been revised to include guidance about the Pneumococcal 15-valent Conjugate vaccine code 90671 that became effective for dates of service on or after July 16, 2021. You can read more about the different types of available pneumococcal vaccines in a related MMP article (link).
  • MLN MM12439: (link)

Medicare Coverage Updates

Transvenous (Catheter) Pulmonary Embolectomy National Coverage Determination (NCD) Section 240.6
  • Article Release Date: December 20, 2021
  • What You Need to Know: CMS has removed the NCD for Transvenous Pulmonary Embolectomy (TPE) and in the absence of an NCD, your MAC will make coverage determinations for this procedure.
  • MLN MM12537: (link)

Beth Cobb

December & Early January 2022 COVID-19 and Other Medicare Updates
Published on Jan 05, 2022
20220105
 | Billing 
 | Coding 

COVID-19 Updates

December 16, 2021: MLN Connects Reminder: Changes for MA Plan Claims Starting January 1, 2022

CMS reminded providers in the December 16 edition of MLN Connects (link) that “if you vaccinate or administer monoclonal antibody treatment to patients enrolled in Medicare Advantage (MA) plans on or after January 1, 2022, submit claims to the MA Plan. Original Medicare won’t pay these claims.”

December 22nd & 23rd, 2021: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 by Pfizer
  • December 22nd: The FDA announced (link) the issuance of an Emergency Use Authorization (EUA) for Pfizer’s Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients twelve years and older weighing at least 40 kilograms.
  • December 23rd: The FDA announced (link) the issuance of an EUA for Merck’s molnupiravir to treat mild-to-moderate COVID-19 in adults with a positive test for the disease and “who are at high risk for progression to severe COVID-19, including hospitalization or death.”
December 24, 2021: CDC Health Advisory – Rapid Increase of Omicron Variant Infections in the United States

The CDC released an official CDC Health Advisory (link) containing updated recommendations “to enhance protection for healthcare personnel, patients, and visitors, and ensure adequate staffing in healthcare facilities” in response to the increased transmissibility of the Omicron variant.

December 31, 2021: CDC Health Advisory – Using Therapeutics to Prevent and Treat COVID-19

In this Health Advisory (link), the CDC acknowledges that the SARS-CoV-2 Omicron variant has become the dominant variant of concern in the United States and that there are therapeutics available for preventing and treating COVID-19 in specific at risk populations. The CDC notes that this advisory “serves to familiarize healthcare providers with available therapeutics, understand how and when to prescribe and prioritize them, and recognize contraindications.

January 3, 2022: FDA Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine

The FDA announced (link) amendments to the EUA for the Pfizer-BioNTech COVID-19 vaccine to:

  • “Expand the use of a single booster dose to include use in individuals 12 through 15 years of age,
  • Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months, and
  • Allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.”

Other Updates

Revised MLN Fact Sheet: Intravenous Immune Globulin (IVIG) Demonstration

CMS noted in the December 23rd Edition of MLN Connects that the IVIG Demonstration Fact Sheet (link) has been revised to add the 2022 payment rate for Q2052 and added Asceniv (J1554) to the list of drugs covered in this demonstration.

December 16, 2021: Medicare Clinical Laboratory Fee Schedule Private Payor Data Reports – Delayed until 2023

CMS included the following information in the December 16th Edition of MLN Connects (link):

“On December 10, the Protecting Medicare and American Farmers from Sequester Cuts Act delayed the Clinical Laboratory Fee Schedule private payor reporting requirement:

  • Next data reporting period is January 1 – March 31, 2023
  • Reporting is based on the original data collection period, January 1 – June 30, 2019

The Act also extended the statutory phase-in of payment reductions resulting from private payor rate implementation:

  • No payment reductions for Calendar Years (CYs) 2021 and 2022
  • Payment won’t be reduced by more than 15% for CYs 2023 through 2025

Visit the PAMA Regulations webpage for more information on what data you need to collect and how to report it.”

December 21, 2021: Medicare Overpayment for Chronic Care Services

Palmetto GBA, the Medicare Administrative Contractor (MAC) for Jurisdictions J and M published a notice (link) regarding overpayments for Chronic Care Management (CCM) Services noting that the MACs have been directed by CMS to recoup CCM Services claims identified as overpayments by the OIG.

December 27, 2021: CMS Posts FAQ Document regarding Good Faith Estimates (GFEs) for uninsured (and self-pay) Individuals

The CMS has posted an FAQ document (link) regarding implementation of Section 112 of Title I (the No Surprises Act (NSA)). The very first FAQ is a reminder that “providers and facilities are required to provide GFEs to uninsured (or self-pay) individuals in connection with items or services scheduled, or upon the request of the uninsured (self-pay) individual, on or after January 1, 2022.”

December 28, 2021: CMS Removed CPT Code from Prior Authorization and Pre-Claim Review Initiatives

CMS posted the following update (link) to their Prior Authorization for Certain Hospital Outpatient Department (OPD) Services webpage:

“Beginning for dates of service on or after January 7, 2022, CMS is removing CPT 67911 (correction of lid retraction) from the list of codes that require prior authorization as a condition of payment. This service is not likely to be cosmetic in nature and commonly occurs secondary to another condition. The full list of HCPCS codes has been updated to reflect this change.”

Beth Cobb

P.A.R. Pro Tips: News from the MACs
Published on Dec 15, 2021
20211215
 | Billing 
 | Coding 
 | OIG 

MMP’s Protection Assessment Report (P.A.R.) combines current Medicare Fee-for-Service review targets (i.e. MAC, RAC, OIG, etc.) with hospital specific paid claims data made possible through a collaboration with RealTime Medicare Data (RTMD). Monthly, our newsletter spotlights current review activities. This month we highlight recent CMS and Medicare Administrative Contractor (MAC) eNews reminders for Providers.

P.A.R. PRO TIPS: eNews Reminders for Providers

November 29, 2021: WPS J8 eNews: Prior Authorization for Hospital Outpatient Department Services Tips and Reminders

After noting they continue to find errors, including omissions, on prior authorization requests that may result in processing delays, WPS offered the following tips and reminders related to the CME Prior Authorization for Hospital Outpatient Department Services Program (link) in their daily eNews:

Vein Ablation

  • Prior authorization requests should clearly identify which extremity and vein(s) the request is for, and
  • Documentation should include conservative measures and the length of time the conservative measures were tried.
    • Implantation of Spinal Neurostimulators

      • The Unique Tracking Number (UTN) assigned to an affirmed implantation of spinal neurostimulators trial is the same UTN that shall be used for the permanent implantation,
      • A new UTN for the permanent implantation is only required if more than 120 days have passed since the trial UTN was issued or if the trial and permanent Provider Transaction Numbers (PTANs) are different, and
      • Documentation should include a psychiatric evaluation and support of tried and failed conservative treatment.

      WPS provides a more detailed article on their website about this program (link)

      December 1, 2021: Palmetto GBA eNews: Aftercare, Musculoskeletal System and Connective Tissue Diagnosis Related Groups (DRGs)

      “This article (link) includes a description of the DRG codes for Aftercare, Musculoskeletal System and Connective Tissue and a list of Principal Diagnosis Tips. Please review this information and share it with your staff.” For example, Palmetto advises that ICD-10-CM Diagnosis code M48.4 (Fatigue fracture of vertebra, should not be used for acute traumatic fracture.

      Comprehensive Error Rate Testing (CERT) Question & Answer Fact Sheet

      A second article of interest (link) in Palmetto’s December 1st eNews answers who, what and how questions about the CERT. For example:

      • Question: “Are healthcare providers required to comply with CERT’s request for medical records?
      • Answer: Yes, the CERT is a federally mandated program. Non-submission of medical records will result in a denial of all services billed on the claim.”
      December 2, 2021: CMS MLN Connects eNews: Skilled Nursing Care & Skilled Therapy Services to Maintain Function or Prevent or Slow Decline

      CMS included the following reminder to providers in the December 2nd edition of MLN Connects (link):

      “Medicare covers skilled nursing care and skilled therapy services under skilled nursing facility, home health, and outpatient therapy benefits when a beneficiary needs skilled care to maintain function or to prevent or slow decline, as long as:

      • The beneficiary requires skilled care for the services to be provided safely and effectively
      • An individualized assessment of the patient's condition demonstrates that the specialized judgment, knowledge, and skills of a qualified therapist are needed for a safe and effective maintenance program

      Visit the Jimmo Settlement Agreement webpage for more information.”

      December 2, 2021: Palmetto GBA eNews: Responding to CERT Documentation Request

      As a follow-up to the previously mentioned CERT FAQ document, Palmetto published an article (link) detailing why you are required to respond to CERT requests, what you need to send, and where to send the documentation to.

      December 7, 2021: Novitas Solutions JL eNews: Prior Authorization: Cervical fusion with disc removal

      Novitas noted in their eNews that the A/B MAC Prior Authorization Collaboration Workgroup has published an article (link) about cervical fusions with disc removal and reminds providers that this procedure is part of the prior authorization program for certain hospital outpatient department services.

      December 10, 2021: Protecting Medicare and American Farmers from Sequester Cuts Act

      President Biden signed this Act into law on December 10th (link) and while this is not a Pro Tip, passage of this Act does impact hospitals. Among other items in the Act, it amends the CARES Act to extend the 2 percent sequestration suspension until March 31, 2022. Beginning April 1, 2022, and ending June 30, 2022, the sequestration payment reduction will be 1.0 percent. The full 2 percent Medicare sequester cut will begin again on July 1, 2022.

Beth Cobb

No Results Found!

Yes! Help me improve my Medicare FFS business.

Please, no soliciting.

Thank you! Someone will contact you soon.
Oops! Something went wrong while submitting the form.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.